Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiol

Contraception

Volumn 54, Issue 5, 1996, Pages 299-304

  Spona, J ^a,b,c,f   Feichtinger, W ^d   Kindermann, Ch ^d   Wunsch C ^e   Brill, K ^e  

^a Department of Medicine III   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d Institute for Sterility Treatment   (Austria)

^e BAYER PHARMA AG   (Germany)

^f LAB 19 ^*  (Austria)

Author keywords

follicle growth; levonorgestrel; oral contraceptives

Indexed keywords

CORTICOTROPIN BINDING GLOBULIN; ESTRADIOL; ETHINYLESTRADIOL; FOLLITROPIN; LEVONORGESTREL; LUTEINIZING HORMONE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIUM; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OVARY FUNCTION; OVULATION INHIBITION;

EID: 0030298380     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(96)00183-7     Document Type: Article

References (18)

1. 1. Lachnit-Fixson U. Development and clinical evaluation of triphasic oral contraception. In: Elstein M, ed. Update on triphasic oral contraception. Amsterdam:Excerpta Medica, 1982:37-53.
2. 2. Spona J, Lachnit-Fixson U, Düsterberg B, Dobianer K. Inhibition of ovulation by triphasic gestodene-containing oral contraceptive. Adv Contracept 1993;9: 187-94.
3. 3. Committee on Safety of Drugs. Combined oral contraceptives. A statement by the Committee on Safety of Drugs. Br Med J 1970;1:231-2.
4. 4. Jeffcoat TNA. RCOG Statement on oral contraceptives. Br Med J 1970;1:293.
5. 5. Gerstman BB, Piper JM, Tomita DK, et al. Oral contraceptive estrogen dose and risk of deep venous thromboembolic disease. Am J Epidemiol 1991;133:32-6.
6. 6. Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. B Med J 1993;306:956-63.
7. 7. Mishell DR Jr. Oral contraception: past, present and future perspectives. Int J Fertil 1991;36:7-18.
8. 8. Fotherby K, Caldwell ADS. The new low dose oral contraceptives. Br J Obstet Gynaecol 1994;14:327-32.
9. 9. Apelo R, Veloso I. Clinical experience with ethinylestradiol and d-norgestrel as an oral contraceptive. Fertil Steril 1975;26:283-8.
10. 10. Bergstein NAM. Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives. Acta Obstet Gynecol Scand Suppl 1976;54: 51-9.
11. 11. Bye PGT. Analysis of a multicenter trial of a new low dose oral contraceptive in Great Britain. Obstet General Scand Suppl 1976;54:61-6.
12. 12. Prasad RNV, Koh S, Ratnam SS. Effects of three types of combined oral contraceptive pills on blood coagulation, fibrinolysis and platelet function. Contraception 1989; 39:369-83.
13. 13. Spona J, Schneider WHF, Biegelmeyer C et al. Ovulation inhibition with different doses of levonorgestrel and other progestogens; clinical and experimental investigation. Acta Obstet Gynecol Scand Suppl 1979;88: 7-15.
14. 14. Fitzgerald C, Feichtinger W, Spona J, et al. Comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation. Adv Contracept 1994;10:5-18.
15. 15. Van der Vange N. Ovarian activity during low-dose oral contraceptives. In: Chamberlain G, eds. Contemporary Obstetrics and Gynecology. London: Butterworths 1988:315-26.
16. 16. Mall-Haefeli M, Werner-Zodrow I, Huber PR, et al. Oral contraception and ovarian function. In: Runnebaum B, Rabe T, Kiesel L, eds. Female Contraception. Berlin-:Springer-Verlag, 1988:97-105.
17. 17. Elstein M, Bristow PG, Hewitt KJ et al. Effects of a low estrogen oral contraceptive on urinary excretion of luteinising hormone and ovarian steroids. Br Med J 1974; 1:11-3.
18. 18. Wenzl R, Bennink HC, Van Beek R, et al. Inhibition with a combined oral contraceptive containing 1 mg micronized 17β-estradiol. Fert Steril 1993;60:616-9.